Dihydroartemisinin and Gefitinib Synergistically Inhibit NSCLC Cell Growth and Promote Apoptosis via the Akt/mTOR/Stat3 Pathway
Molecular Medicine Reports - Greece
doi 10.3892/mmr.2017.6989
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Spandidos Publications